Status:

COMPLETED

Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Lead Sponsor:

Slotervaart Hospital

Collaborating Sponsors:

AstraZeneca

Isala

Conditions:

Hyperglycemia Steroid-induced

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Purpose of this study is to treat glucocorticoid induced hyperglycemia due to glucocorticoid pulse therapy in a efficacious, safe and convenient way. Patients with acute exacerbation of COPD treated w...

Detailed Description

Rationale: Patients hospitalized for COPD exacerbation treated with high dose glucocorticoids, frequently develop hyperglycaemia. Currently, sliding scale insulin is often used to bridge such episodes...

Eligibility Criteria

Inclusion

  • Informed consent
  • Hospitalization due to AECOPD
  • Treatment with ≥30mg prednisone daily or equivalent dose of glucocorticoid for AECOPD
  • An expected duration of glucocorticoid treatment of 3-14 days at study entry
  • Known type 2 diabetes or glucose ≥ 10 mmol/l at admission

Exclusion

  • High dose glucocorticoid treatment started ≥7 days before study entry
  • Need for ICU admission
  • Chronic kidney disease stage G3 (glomerular filtration rate \<60ml/minute)
  • Recurrent genital or urinary tract infection
  • Current use of any SGLT-2 inhibiting agent
  • Suspected volume depletion
  • Congestive heart failure functional classification NYHA class IV/IV or instable heart failure
  • Acute stroke within 2 months before inclusion.
  • Recent cardiovascular event: acute coronary syndrome, hospitalisation for unstable angina or coronary revascularisation within 2 months before inclusion
  • Suspected liver disease, confirmed by AST/ALT \> 3x ULN or bilirubin \>2.0mg/dl (34.2 μmol/l) or serologically proven infection with hepatitis B or hepatitis C
  • Pregnancy or breast feeding

Key Trial Info

Start Date :

February 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2017

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT02253121

Start Date

February 1 2015

End Date

May 1 2017

Last Update

May 22 2018

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Slotervaart Hospital

Amsterdam, Netherlands, 1066 EC

2

OLVG West

Amsterdam, Netherlands

3

Spaarne Ziekenhuis

Hoofddorp, Netherlands

4

Isala

Zwolle, Netherlands